Ocular manifestations of injection drug use

Infectious Disease Clinics of North America

Volumn 16, Issue 3, 2002, Pages 607-622

  Kim, Rubin W ^a   Juzych, Mark S ^a   Eliott, Dean ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TALC;

BACTERIAL INFECTION; BLINDNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE TRANSMISSION; EMBOLISM; ENDOPHTHALMITIS; EYE INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MYCOSIS; PARTICULATE MATTER; RETINA ARTERY OCCLUSION; REVIEW; SYSTEMIC DISEASE; TREATMENT PLANNING; VISUAL IMPAIRMENT;

CANDIDA; ENDOPHTHALMITIS; FUNGI; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0036738207     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(02)00013-2     Document Type: Review

References (84)

1. Kreeger R, Pearson PA, Bullock JD, et al. Endophthalmitis associated with intravenous drug abuse. Ann Emerg Med 1987;16:585-7.
2. Lederer Jr. CM, Sabates FN. Ocular findings in the intravenous drug abuser. Ann Ophthalmol 1982;14:436-8.
3. From the Centers for Disease Control. Aspergillus endophthalmitis in intravenous-drug users-Kentucky. JAMA 1990;263:941.
4. Aguilar GL, Blumenkrantz MS, Egbert PR, et al. Candida endophthalmitis after intravenous drug abuse. Arch Ophthalmol 1979;97:96-100.
5. Doft BH, Clarkson JG, Rebell G, et al. Endogenous Aspergillus endophthalmitis in drug abusers. Arch Ophthalmol 1980;98:859-62.
6. Elliott JH, O'Day DM, Gutow GS, et al. Mycotic endophthalmitis in drug abusers. Am J Ophthalmol 1979;88:66-72.
7. Getnick RA, Rodrigues MM. Endogenous fungal endophthalmitis in a drug addict. Am J Ophthalmol 1974;77:680-3.
8. Griffin JR, Pettit TH, Fishman LS, et al. Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases. Arch Ophthalmol 1973;89:450-6.
9. Grossniklaus H, Bruner WE, Frank KE, et al. Bacillus cereus panophthalmitis appearing as acute glaucoma in a drug addict. Am J Ophthalmol 1985;100:334-5.
10. Hatem G, Merritt JC, Cowan Jr. CL. Bacillus cereus panophthalmitis after intravenous heroin. Ann Ophthalmol 1979;11:431-40.
11. Masi RJ. Endogenous endophthalmitis associated with bacillus cereus bacteremia in a cocaine addict. Ann Ophthalmol 1978;10:1367-70.
12. Michelson JB, Friedlaender MH. Endophthalmitis of drug abuse. Int Ophthalmol Clin 1987;27:120-6.
13. Schlossberg D, Jan AM. Endophthalmitis in intravenous drug abuse. Ann Ophthalmol 1993;25:77-8.
14. Sugar HS, Mandell GH, Shalev J. Metastatic endophthalmitis associated with injection of addictive drugs. Am J Ophthalmol 1971;71:1055-8.
15. Wilmarth SS, May DR, Roth AM, et al. Aspergillus endophthalmitis in an intravenous drug user. Ann Ophthalmol 1983;15:470-6.
16. Weishaar PD, Flynn Jr. HW, Murray TG, et al. Endogenous Aspergillus endophthalmitis. Clinical features and treatment outcomes. Ophthalmology 1998;105:57-65.
17. Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol 1979;23:279-96.
18. Wilhelmus KR. The pathogenesis of endophthalmitis. Int Ophthalmol Clin 1987;27:74-81.
19. Samiy N, D'Amico DJ. Endogenous fungal endophthalmitis. Int Ophthalmol Clin 1996; 36:147-62.
20. Palestine AG, Rodrigues MM, Macher AM, et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 1984;91:1092-9.
21. Snip RC, Michels RG. Pars plana vitrectomy in the management of endogenous Candida endophthalmitis. Am J Ophthalmol 1976;82:699-704.
22. Stone RD, Irvine AR, O'Connor GR. Candida endophthalmitis: report of an unusual case with isolation of the etiologic agent by vitreous biopsy. Ann Ophthalmol 1975;7:757-62.
23. Henderson DK, Edwards Jr. JE, Ishida K, et al. Experimental hematogenous Candida endophthalmitis: diagnostic approaches. Infect Immun 1979;23:858-62.
24. Souri EN, Green WR. Intravitreal amphotericin B toxicity. Am J Ophthalmol 1974; 78:77-81.
25. Axelrod AJ, Peyman GA. Intravitreal amphotericin B treatment of experimental fungal endophthalmitis. Am J Ophthalmol 1973;76:584-8.
26. Axelrod AJ, Peyman GA, Apple DJ. Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol 1973;76:578-83.
27. Lance SE, Friberg TR, Kowalski RP. Aspergillus flavus endophthalmitis and retinitis in an intravenous drug abuser. A therapeutic success. Ophthalmology 1988;95:947-9.
28. Michelson JB, Freedman SD, Boyden DG. Aspergillus endophthalmitis in a drug abuser. Ann Ophthalmol 1982;14:1051-4.
29. McDonnell PJ, McDonnell JM, Brown RH, et al. Ocular involvement in patients with fungal infections. Ophthalmology 1985;92:706-9.
30. Jampol LM, Dyckman S, Maniates V, et al. Retinal and choroidal infarction from Aspergillus: clinical diagnosis and clinicopathologic correlations. Trans Am Ophthalmol Soc 1988;86:422-40.
31. Roney P, Barr CC, Chun CH, et al. Endogenous aspergillus endophthalmitis. Rev Infect Dis 1986;8:955-8.
32. Gross JG. Endogenous Aspergillus-induced endophthalmitis. Successful treatment without systemic antifungal medication. Retina 1992;12:341-5.
33. Bouza E, Grant S, Jordan C, et al. Bacillus cereus endogenous panophthalmitis. Arch Ophthalmol 1979;97:498-9.
34. Cowan Jr. CL, Madden WM, Hatem GF, et al. Endogenous Bacillus cereus panophthalmitis. Ann Ophthalmol 1987;19:65-8.
35. Hemady R, Zaltas M, Paton B, et al. Bacillus-induced endophthalmitis: new series of 10 cases and review of the literature. Br J Ophthalmol 1990;74:26-9.
36. Young EJ, Wallace Jr. RJ, Ericsson CD, et al. Panophthalmitis due to Bacillus cereus. Arch Intern Med 1980;140:559-60.
37. Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 1994;101:832-8.
38. Atlee Jr. WE. Talc and cornstarch emboli in the eyes of drug abusers. JAMA 1972;219:49-51.
39. Michelson JB, Whitcher JP, Wilson S, et al. Possible foreign body granuloma of the retina associated with intravenous cocaine addiction. Am J Ophthalmol 1979;87:278-80.
40. Tse DT, Ober RR. Talc retinopathy. Am J Ophthalmol 1980;90:624-40.
41. Kresca LJ, Goldberg MF, Jampol LM. Talc emboli and retinal neovascularization in a drug abuser. Am J Ophthalmol 1979;87:334-9.
42. Jampol LM, Setogawa T, Rednam KR, et al. Talc retinopathy in primates. A model of ischemic retinopathy: I. clinical studies. Arch Ophthalmol 1981;99:1273-80.
43. Khawly JA, Pollock SC. Litten's sign (Roth's spots) in bacterial endocarditis. Arch Ophthalmol 1994;112:683-4.
44. Centers for Disease Control and Prevention. Weekly surveillance report, November 21: AIDS activity. Atlanta (Ga): Centers for Disease Control and Prevention; 1983. p. 11-21.
45. Glasgow BJ. Evidence for breaches of the retinal vasculature in acquired immune deficiency syndrome angiopathy. A fluorescent microsphere study. Ophthalmology 1997;104:753-60.
46. Jabs DA, Green WR, Fox R, et al. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989;96:1092-9.
47. Mines JA, Kaplan HJ. Acquired immunodeficiency syndrome (AIDS): the disease and its ocular manifestations. Int Ophthalmol Clin 1986;26:73-115.
48. Pepose JS, Holland GN, Nestor MS, et al. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology 1985;92:472-84.
49. Dugel PU, Rao NA. Ocular infections in the acquired immunodeficiency syndrome. Int Ophthalmol Clin 1993;33:103-27.
50. Kestelyn P, Stevens AM, Bakkers E, et al. Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br J Ophthalmol 1987;71:806-9.
51. Liesegang TJ. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 1991;98:1216-29.
52. Melbye M, Grossman RJ, Goedert JJ, et al. Risk of AIDS after herpes zoster. Lancet 1987;1:728-31.
53. Sandor E, Croxson TS, Millman A, et al. Herpes zoster ophthalmicus in patients at risk for AIDS. N Engl J Med 1984;310:1118-9.
54. Sandor EV, Millman A, Croxson TS, et al. Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS). Am J Ophthalmol 1986;101: 153-5.
55. Sellitti TP, Huang AJ, Schiffman J, et al. Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am J Ophthalmol 1993; 116:297-301.
56. Shuler JD, Engstrom Jr. RE, Holland GN. External ocular disease and anterior segment disorders associated with AIDS. Int Ophthalmol Clin 1989;29:98-104.
57. Cunningham Jr. ET, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med 1998;339:236-44.
58. Ryan-Graham MA, Durand M, Pavan-Langston D. AIDS and the anterior segment. Int Ophthalmol Clin 1998;38:241-63.
59. Robinson MR, Udell IJ, Garber PF, et al. Molluscum contagiosum of the eyelids in patients with acquired immune deficiency syndrome. Ophthalmology 1992;99:1745-7.
60. Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet 1996;348:659-63.
61. Engstrom RE, Holland GN. Chronic herpes zoster virus keratitis associated with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988;105:556-8.
62. Young TL, Robin JB, Holland GN, et al. Herpes simplex keratitis in patients with acquired immune deficiency syndrome. Ophthalmology 1989;96:1476-9.
63. Holland GN. Acquired immunodeficiency syndrome and ophthalmology: the first decade. Am J Ophthalmol 1992;114:86-95.
64. Engstrom Jr. RE, Holland GN, Hardy WD, et al. Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol 1990;109:153-61.
65. Pomerantz RJ, Kuritzkes DR, de la Monte SM, et al. Infection of the retina by human immunodeficiency virus type I. N Engl J Med 1987;317:1643-7.
66. Graham K, Pinnolis M. AIDS and the posterior segment. Int Ophthalmol Clin 1998; 38:265-80.
67. Gallant JE, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992;166:1223-7.
68. Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related non-infectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-82.
69. Pertel P, Hirschtick R, Phair J, et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992;5:1069-74.
70. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997;124:227-33.
71. Whitcup SM, Cunningham Jr. ET, Polis MA, et al. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy. Br J Ophthalmol 1998;82:845-6.
72. Whitcup SM, Fortin E, Nussenblatt RB, et al. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA 1997;277:1519-20.
73. Chess J, Marcus DM. Zoster-related bilateral acute retinal necrosis syndrome as presenting sign in AIDS. Ann Ophthalmol 1988;20:431-5, 438.
74. Jabs DA, Schachat AP, Liss R, et al. Presumed varicella zoster retinitis in immunocompromised patients. Retina 1987;7:9-13.
75. Carney MD, Peyman GA, Goldberg MF, et al. Acute retinal necrosis. Retina 1986;6:85-94.
76. Fisher JP, Lewis ML, Blumenkranz M, et al. The acute retinal necrosis syndrome. Part 1: clinical manifestations. Ophthalmology 1982;89:1309-16.
77. Clarkson JG, Blumenkranz MS, Culbertson WW, et al. Retinal detachment following the acute retinal necrosis syndrome. Ophthalmology 1984;91:1665-8.
78. Sternberg Jr. P, Han DP, Yeo JH, et al. Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology 1988;95:1389-93.
79. Holland GN, Engstrom Jr. RE, Glasgow BJ, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988;106:653-67.
80. Parke DW, Font RL. Diffuse toxoplasmic retinochoroiditis in a patient with AIDS. Arch Ophthalmol 1986;104:571-5.
81. Smith RE. Toxoplasmic retinochoroiditis as an emerging problem in AIDS patients. Am J Ophthalmol 1988;106:738-9.
82. Engstrom Jr. RE, Holland GN, Nussenblatt RB, et al. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 1991;111:601-10.
83. Hicks CB, Benson PM, Lupton GP, et al. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med 1987;107:492-5.
84. Dugel PU, Rao NA, Forster DJ, et al. Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. Am J Ophthalmol 1990;110:113-7.